In the United States a disease is considered rare if fewer than 200,000 Americans have it. About 7,000 diseases meet this criterion, and the number...

There’s life down there, deep beneath the ocean floor. Recently reported from scientists at Woods Hole Oceanographic Institute where they collected...

Successful pharmaceutical outsourcing requires realistic and well-defined expectations, a strong vendor-client relationship, and continued client...

The internet has connected us in a way never before seen in history: we can now rely on other’s people experiences to guide our own. Whether it is...

From pharmaceuticals to financial services, the motives that drive outsourcing are fundamental. Top among them are perceived cost savings, improved...

Working on the Rare Disease Science Challenge has shown me that everybody wants to support rare disease in many different ways, which is how the...

Last week we blogged about the growing trend in pharmaceutical outsourcing. When people hear the word “outsourcing”, many assume that means that...

Washington University geneticist Dr. Jimmy Lin’s Rare Genomics Institute and Scientist of San Diego have announced the winners of about $500,000 in...

The Be HEARD Rare Disease Science Challenge is entering its next phase. After 77 applicants covering 67 rare diseases, we have decided on service...

By some estimates, the pharmaceutical outsourcing market could grow to $65 billion by 2018, fueled by a compound annual growth rate of nearly 15...